Atlas Trials

Stage III Uterine Sarcoma

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Uterine Sarcoma

RecordFirmDate
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (NCT01764802)Ohio State University Comprehensive Cancer Center2010-10-01
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer (NCT01098630)Gynecologic Oncology Group2010-07-01
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258)University of Southern California2010-06-01
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)National Cancer Institute (NCI)2010-06-01
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery (NCT01553539)Wake Forest University Health Sciences2009-10-01
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies (NCT01079832)Case Comprehensive Cancer Center2009-05-01
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma (NCT00390234)National Cancer Institute (NCI)2006-09-01
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma (NCT00245102)National Cancer Institute (NCI)2005-09-01
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer (NCT00238121)National Cancer Institute (NCI)2005-02-01
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)National Cancer Institute (NCI)2004-05-01

Track Stage III Uterine Sarcoma automatically

Every clearance here is in the API, with alerts when new ones post.